Eurand, Inc. v. Impax Laboratories, Inc.

O’MALLEY, Circuit Judge.

Impax Laboratories, Inc. (“Impax”) appeals from the November 8, 2011 decision of the United. States District Court for the District of Delaware explicitly adding Im-pax to a preliminary injunction originally entered in May 2011. The injunction barred all generic versions of AMRIX® from the market. Because Impax was subject to the May 2011 injunction and failed to file a timely appeal, we lack jurisdiction over Impax’s appeal of the district court’s November 8, 2011 order clarifying that injunction. Impax also complains of the district court’s failure to require…